ONC · BeOne Medicines Ltd.
$347.48
-8.53 (-2.40%)
At close · Aug 14
Market Cap
$513.62B
Shares
1.48B
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Elizabeth F. Mooney | director | Appointed | 2026-06-11 |
| Felix J. Baker | director | Appointed | 2026-06-11 |
| Dr. Lai Wang | President, Global Head of Research and Development | Appointed | 2025-12-18 |
| Shalini Sharp | Class III director | Appointed | 2024-09-26 |
| Julia Wang | CFO | Resigned | 2024-07-18 |
| Aaron Rosenberg | Chief Financial Officer | Appointed | 2024-07-18 |
| Titus Ball | principal accounting officer | Appointed | 2024-03-20 |
| Olivier Brandicourt | Class II director | Appointed | 2024-01-23 |
| Thomas Malley | member of the Board of Directors | Resigned | 2024-01-23 |
| Timothy Chen | Board of Directors | Resigned | 2022-06-22 |
Key facts
CIK
1651308
CUSIP
07725L102
13F (30d)
288 filings
263 filers
Visit website
Investor relations